Dasatinib tablets 50mg “BMSH” by Bristol-Myers Squibb Sales contains dasatinib hydrate and is used to treat Philadelphia chromosome-positive (Ph+) chronic myeloid leukemia (CML) and acute lymphoblastic leukemia (ALL). It is available as a 50mg 1 tablet formulation with YJ code 4291020F2074.
Dasatinib tablets 50mg “BMSH”
Need more detailed information?
Contact TASAKI PHARMA for inquiries about this medicine (English support available).
Contact us about this drug →
